General Information of Drug Formulation (ID: F05856)

Formulation Name
Didanosine 125 mg capsule
Company
Bristol-Myers Squibb Company
Pharmaceutical Drug(s) in Formulation
Drug Name Drug ID Indication ICD 11 Status
Didanosine DMI2QPE Human immunodeficiency virus infection 1C62 Approved
Pharmaceutical Excipient(s) in Formulation
Excipient Name Excipient ID PubChem CID Functional Classification
Carboxymethylcellulose sodium E00621 Not Available Adsorbent; Binding agent; Disintegrant; Emulsifying agent; Suspending agent; Viscosity-controlling agent
Diethyl phthalate E00135 6781 Plasticizing agent; Solvent
Sodium hydroxide E00234 14798 Alkalizing agent
Talc E00520 16211421 Anticaking agent; Diluent; Glidant; lubricant
Titanium dioxide E00322 26042 Coating agent; Colorant; Opacifying agent